The use of anthrax as a bioweapon is rare, but devastating. This new treatment might one day save people that are beyond the “point of no return.” ...

Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But once ...

University of Pittsburgh researchers discovered that a mix of growth factors can rescue cells from late-stage anthrax damage ...

Results provide proof-of-concept that ERK pathway reactivation might be an effective, biologically based therapy to prevent anthrax-induced lethality.

Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But once ...

The Global Anthrax Vaccine Market is expected to grow at a steady CAGR of 6.7%, fueled by increasing bioterrorism threats and growing awareness about the disease. As of 2022, the market was valued at ...

Researchers show that a cocktail of growth factors reversed would-be lethal cell damage in mice with anthrax, suggesting that this approach could be adapted for use in patients. Anthrax ...

Dick Wolf’s Wolf Entertainment, USG Audio, the podcast division of Universal Studio Group, and Jeremiah Crowell’s Dig Studios ...

Abia State Government official said the campaign became necessary following a recent anthrax outbreak in cattle in Nasarawa, ...